Respiratory illness season generally runs from November to March. It can take two weeks to build immunity after receiving ...

Aspyre Foods is building a platform to turn duckweed into a biofactory for producing two highly functional food proteins: ...

Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...

This patent moves researchers one step closer to developing a universal vaccine for leptospirosis, a widely neglected ...

The VTT Technical Research Centre of Finland has challenged a key patent filed by The Every Company at the European Patent ...

India-based alternative feed startup Loopworm has opened a Series A funding round in support of its goal of scaling ...

In this GEN webinar, our expert speakers will present a case study demonstrating the exceptional properties and high-fidelity performance of ENFINIA Linear DNA.

RemeGen (688331.SH/09995.HK) announced that the 48-week open-label extension (OLE) data from China Phase III clinical study of telitacicept (RC18, brand name: 泰爱®, a BLyS/APRIL dual-target fusion ...

Aging research is increasingly focused on proteins that regulate DNA repair, metabolism, cell survival and tissue renewal.

Telitacicept is approved in China for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and generalized myasthenia gravis (gMG). A global Phase 3 clinical trial in gMG is currently ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

Under the agreement, CSL will fully fund VarmX’s phase 3 trial of its lead candidate, VMX-C001, and retains an exclusive ...